BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33728760)

  • 1. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.
    Onishi Y; Yoshida Y; Takao T; Tahara T; Kikuchi T; Kobori T; Kubota T; Shimmei A; Iwamoto M; Kasuga M
    J Diabetes Investig; 2022 Feb; 13(2):386-390. PubMed ID: 33728760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substitution of telemedicine for clinic visit during the COVID-19 pandemic of 2020: Comparison of telemedicine and clinic visit.
    Onishi Y; Ichihashi R; Yoshida Y; Tahara T; Kikuchi T; Kobori T; Kubota T; Iwamoto M; Hamano S; Kasuga M
    J Diabetes Investig; 2022 Sep; 13(9):1617-1625. PubMed ID: 35524476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan.
    Endo K; Miki T; Itoh T; Kubo H; Ito R; Ohno K; Hotta H; Kato N; Matsumoto T; Kitamura A; Tamayama M; Wataya T; Yamaya A; Ishikawa R; Ooiwa H
    Intern Med; 2022; 61(1):37-48. PubMed ID: 34980759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the State of Emergency Declaration for Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic Suppression on Individuals with Type 1 Diabetes Mellitus.
    Mochizuki S; Miura J; Takagi S; Takita M; Takaike H; Babazono T
    Intern Med; 2024 May; 63(9):1197-1205. PubMed ID: 38369358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
    Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
    Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.
    Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M
    BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan.
    Takahara M; Watanabe H; Shiraiwa T; Maeno Y; Yamamoto K; Shiraiwa Y; Yoshida Y; Nishioka N; Katakami N; Shimomura I
    J Diabetes Investig; 2022 Feb; 13(2):375-385. PubMed ID: 33768726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
    Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
    Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic.
    Jin J; Lee SW; Lee WK; Jeon JH; Kim JG; Lee IK; Choi YK; Park KG
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1142-1146. PubMed ID: 34674507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown.
    Tanji Y; Sawada S; Watanabe T; Mita T; Kobayashi Y; Murakami T; Metoki H; Akai H
    Diabetes Res Clin Pract; 2021 Jun; 176():108840. PubMed ID: 33933499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes.
    Sutkowska E; Marciniak DM; Sutkowska K; Biernat K; Mazurek J; Kuciel N
    Endocrine; 2022 May; 76(2):273-281. PubMed ID: 35072900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Control, Renal Progression, and Use of Telemedicine Phone Consultations Among Japanese Patients With Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Retrospective Cohort Study.
    Sankoda A; Nagae Y; Waki K; Sze WT; Oba K; Mieno M; Nangaku M; Yamauchi T; Ohe K
    JMIR Diabetes; 2023 Nov; 8():e42607. PubMed ID: 37315193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Pharmacist-Led Telemedicine on A1c Reduction During the COVID-19 Pandemic.
    Ahmed F; Hammad S; Redmann O; Smith C; Edwards C; Kader C; Hammoudeh D; Zeidan R
    Telemed J E Health; 2024 Jan; 30(1):166-172. PubMed ID: 37294586
    [No Abstract]   [Full Text] [Related]  

  • 14. Year-long effects of COVID-19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single-center retrospective study.
    Tsukaguchi R; Murakami T; Yoshiji S; Shide K; Fujita Y; Ogura M; Inagaki N
    J Diabetes Investig; 2022 Dec; 13(12):2063-2072. PubMed ID: 35980313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 pandemic on the glycemic control, eating habits, and body compositions of people with diabetes mellitus: A retrospective longitudinal observational study.
    Sawada M; Ohkuma K; Aihara M; Doi S; Sekine R; Kaneko T; Iimuro S; Ichi I; Usami S; Ohe K; Yamauchi T; Kubota N
    J Diabetes Investig; 2023 Feb; 14(2):321-328. PubMed ID: 36346131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical effectiveness of telephone consultation compared to face-to-face consultation in terms of glycaemic control among patients with suboptimally controlled type 2 diabetes: a retrospective cohort study.
    Koh ZWJ; Sim SZ; Lew KJ; Lee PSS; Lee ES
    BMJ Open; 2023 May; 13(5):e063094. PubMed ID: 37160388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of clinic follow-up visits on body weight control in people with prediabetes or diabetes mellitus: Japanese nonelderly cohort study.
    Ono S; Ono Y; Matsui H; Yasunaga H
    Fam Pract; 2017 Sep; 34(5):552-557. PubMed ID: 28369304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.
    Bouchi R; Sugiyama T; Goto A; Ohsugi M; Yoshioka N; Katagiri H; Mita T; Hirota Y; Ikegami H; Matsuhisa M; Araki E; Yokoyama H; Minami M; Yamazaki K; Jinnouchi H; Ikeda H; Fujii H; Nogawa M; Kaneshige M; Miyo K; Ueki K
    J Diabetes Investig; 2023 Aug; 14(8):994-1004. PubMed ID: 37183588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes.
    Wong R; Vaddavalli R; Hall MA; Patel MV; Bramante CT; Casarighi E; Johnson SG; Lingam V; Miller JD; Reusch J; Saltz M; Stürmer T; Tronieri JS; Wilkins KJ; Buse JB; Saltz J; Huling JD; Moffitt R;
    Diabetes Care; 2022 Nov; 45(11):2709-2717. PubMed ID: 36098660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Was the Change in Telehealth Usage and Proportion of No-show Visits for an Orthopaedic Trauma Clinic During the COVID-19 Pandemic?
    Siow MY; Walker JT; Britt E; Kozy JP; Zanzucchi A; Girard PJ; Schwartz AK; Kent WT
    Clin Orthop Relat Res; 2020 Oct; 478(10):2257-2263. PubMed ID: 32639309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.